REQUEST A DEMO
Total
USD $0.00
Search more companies

Hemofarm d.o.o. (Bosnia and Herzegovina)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hemofarm d.o.o. Profile Updated: October 09, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English Download a sample report

Hemofarm is the Bosnian subsidiary of Serbia-based pharmaceuticals maker Hemofarm AD. The Serbian company, which has history dating back to 1960, was acquired by German pharmaceutical group Stada in 2006. Hemofarm’s product portfolio includes medicines, herbal products, dietetics, cosmetics and personal hygiene products. Its customer base comprises drugstores and hospitals across Bosnia and abroad.

Headquarters
Novakovici Bb Str.
Banja Luka; Banja Luka; Postal Code: 78000

Contact Details: Purchase the Hemofarm d.o.o. report to view the information.

Website: http://www.hemofarm.com/o-nama/predstavnistva

Basic Information
Total Employees:
Purchase the Hemofarm d.o.o. report to view the information.
Outstanding Shares:
Purchase the Hemofarm d.o.o. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Hemofarm d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BAM. Absolute financial data is included in the purchased report.
Net sales revenue
7.48%
Total operating revenue
7.48%
Operating profit (EBIT)
-26.09%
EBITDA
-13.63%
Net Profit (Loss) for the Period
-33.52%
Total assets
13.75%
Total equity
5.55%
Operating Profit Margin (ROS)
-2.61%
Net Profit Margin
-2.66%
Return on Equity (ROE)
-2.95%
Debt to Equity Ratio
10.95%
Quick Ratio
-0.06%
Cash Ratio
-0.03%

Similar companies

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?